{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:25:03Z","timestamp":1790717103795,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"35","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2017,8,31]]},"DOI":"10.1038\/onc.2017.112","type":"journal-article","created":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T15:04:42Z","timestamp":1493651082000},"page":"4963-4974","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Bone morphogenetic protein signaling mediated by ALK-2 and DLX2 regulates apoptosis in glioma-initiating cells"],"prefix":"10.1038","volume":"36","author":[{"given":"E","family":"Raja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Komuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Ino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Todo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Morikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Aburatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Koinuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Miyazono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,1]]},"reference":[{"key":"BFonc2017112_CR1","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987\u2013996.","journal-title":"N Engl J Med"},{"key":"BFonc2017112_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/neuonc\/nos273","volume":"15","author":"M Weller","year":"2013","unstructured":"Weller M, Cloughesy T, Perry JR, Wick W . Standards of care for treatment of recurrent glioblastoma\u2014are we there yet? Neuro Oncol 2013; 15: 4\u201327.","journal-title":"Neuro Oncol"},{"key":"BFonc2017112_CR3","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1101\/gad.261982.115","volume":"29","author":"JD Lathia","year":"2015","unstructured":"Lathia JD, Mack SC, Mulkearns-Hubert EE, Valentim CL, Rich JN . Cancer stem cells in glioblastoma. Genes Dev 2015; 29: 1203\u20131217.","journal-title":"Genes Dev"},{"issue":"6","key":"BFonc2017112_CR4","doi-asserted-by":"publisher","first-page":"a021899","DOI":"10.1101\/cshperspect.a021899","volume":"8","author":"Takenobu Katagiri","year":"2016","unstructured":"Katagiri T, Watabe T . Bone morphogenetic proteins. Cold Spring Harb Perspect Biol 2016; 8: pii: a021899.","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"BFonc2017112_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cytogfr.2015.11.009","volume":"27","author":"H Davis","year":"2016","unstructured":"Davis H, Raja E, Miyazono K, Tsubakihara Y, Moustakas A . Mechanisms of action of bone morphogenetic proteins in cancer. Cytokine Growth Factor Rev 2016; 27: 81\u201392.","journal-title":"Cytokine Growth Factor Rev"},{"key":"BFonc2017112_CR6","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nature05349","volume":"444","author":"SG Piccirillo","year":"2006","unstructured":"Piccirillo SG, Reynolds BA, Zanetti N, Lamorte G, Binda E, Broggi G et al. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 2006; 444: 761\u2013765.","journal-title":"Nature"},{"key":"BFonc2017112_CR7","doi-asserted-by":"crossref","first-page":"17920","DOI":"10.18632\/oncotarget.7472","volume":"7","author":"S Liu","year":"2016","unstructured":"Liu S, Yin F, Zhao M, Zhou C, Ren J, Huang Q et al. The homing and inhibiting effects of hNSCs-BMP4 on human glioma stem cells. Oncotarget 2016; 7: 17920\u201317931.","journal-title":"Oncotarget"},{"key":"BFonc2017112_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1089\/cbr.2010.0857","volume":"26","author":"Z Zhou","year":"2011","unstructured":"Zhou Z, Sun L, Wang Y, Wu Z, Geng J, Miu W et al. Bone morphogenetic protein 4 inhibits cell proliferation and induces apoptosis in glioma stem cells. Cancer Biother Radiopharm 2011; 26: 77\u201383.","journal-title":"Cancer Biother Radiopharm"},{"key":"BFonc2017112_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/jb\/mvp148","volume":"147","author":"K Miyazono","year":"2010","unstructured":"Miyazono K, Kamiya Y, Morikawa M . Bone morphogenetic protein receptors and signal transduction. J Biochem 2010; 147: 35\u201351.","journal-title":"J Biochem"},{"key":"BFonc2017112_CR10","doi-asserted-by":"publisher","first-page":"5409","DOI":"10.1038\/onc.2013.67","volume":"32","author":"K Savary","year":"2013","unstructured":"Savary K, Caglayan D, Caja L, Tzavlaki K, Bin Nayeem S, Bergstr\u00f6m T et al. Snail depletes the tumorigenic potential of glioblastoma. Oncogene 2013; 32: 5409\u20135420.","journal-title":"Oncogene"},{"key":"BFonc2017112_CR11","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1101\/gad.235515.113","volume":"28","author":"K Yan","year":"2014","unstructured":"Yan K, Wu Q, Yan DH, Lee CH, Rahim N, Tritschler I et al. Glioma cancer stem cells secrete Gremlin1 to promote their maintenance within the tumor hierarchy. Genes Dev 2014; 28: 1085\u20131100.","journal-title":"Genes Dev"},{"key":"BFonc2017112_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ccr.2007.12.005","volume":"13","author":"J Lee","year":"2008","unstructured":"Lee J, Son MJ, Woolard K, Donin NM, Li A, Cheng CH et al. Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell 2008; 13: 69\u201380.","journal-title":"Cancer Cell"},{"key":"BFonc2017112_CR13","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.stemcr.2015.09.014","volume":"5","author":"H Car\u00e9n","year":"2015","unstructured":"Car\u00e9n H, Stricker SH, Bulstrode H, Gagrica S, Johnstone E, Bartlett TE et al. Glioblastoma stem cells respond to differentiation cues but fail to undergo commitment and terminal cell-cycle arrest. Stem Cell Rep 2015; 5: 829\u2013842.","journal-title":"Stem Cell Rep"},{"key":"BFonc2017112_CR14","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1242\/dev.129.19.4371","volume":"129","author":"G Panganiban","year":"2002","unstructured":"Panganiban G, Rubenstein JL . Developmental functions of the Distal-less\/Dlx homeobox genes. Development 2002; 129: 4371\u20134386.","journal-title":"Development"},{"key":"BFonc2017112_CR15","doi-asserted-by":"publisher","first-page":"8219","DOI":"10.1523\/JNEUROSCI.1344-12.2012","volume":"32","author":"N Ghanem","year":"2012","unstructured":"Ghanem N, Andrusiak MG, Svoboda D, Al Lafi SM, Julian LM, McClellan KA et al. The Rb\/E2F pathway modulates neurogenesis through direct regulation of the Dlx1\/Dlx2 bigene cluster. J Neurosci 2012; 32: 8219\u20138230.","journal-title":"J Neurosci"},{"key":"BFonc2017112_CR16","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1158\/0008-5472.CAN-09-3631","volume":"70","author":"X Wu","year":"2010","unstructured":"Wu X, Rauch TA, Zhong X, Bennett WP, Latif F, Krex D et al. CpG island hypermethylation in human astrocytomas. Cancer Res 2010; 70: 2718\u20132727.","journal-title":"Cancer Res"},{"key":"BFonc2017112_CR17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.diff.2009.10.003","volume":"79","author":"Y Du","year":"2010","unstructured":"Du Y, Yip H . Effects of bone morphogenetic protein 2 on Id expression and neuroblastoma cell differentiation. Differentiation 2010; 79: 84\u201392.","journal-title":"Differentiation"},{"key":"BFonc2017112_CR18","doi-asserted-by":"publisher","first-page":"16659","DOI":"10.1073\/pnas.0407643101","volume":"101","author":"J Hsieh","year":"2004","unstructured":"Hsieh J, Nakashima K, Kuwabara T, Mejia E, Gage FH . Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc Natl Acad Sci USA 2004; 101: 16659\u201316664.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2017112_CR19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.canlet.2009.02.042","volume":"280","author":"AJ Frew","year":"2009","unstructured":"Frew AJ, Johnstone RW, Bolden JE . Enhancing the apoptotic and therapeutic effects of HDAC inhibitors. Cancer Lett 2009; 280: 125\u2013133.","journal-title":"Cancer Lett"},{"key":"BFonc2017112_CR20","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s12032-014-0985-5","volume":"31","author":"P Bezecny","year":"2014","unstructured":"Bezecny P . Histone deacetylase inhibitors in glioblastoma: pre-clinical and clinical experience. Med Oncol 2014; 31: 985.","journal-title":"Med Oncol"},{"key":"BFonc2017112_CR21","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.ijrobp.2015.04.038","volume":"92","author":"AV Krauze","year":"2015","unstructured":"Krauze AV, Myrehaug SD, Chang MG, Holdford DJ, Smith S, Shih J et al. A phase 2 study of concurrent radiation therapy, temozolomide, and the histone deacetylase inhibitor valproic acid for patients with glioblastoma. Int J Radiat Oncol Biol Phys 2015; 92: 986\u2013992.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFonc2017112_CR22","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1021\/cb300655w","volume":"8","author":"AH Mohedas","year":"2013","unstructured":"Mohedas AH, Xing X, Armstrong KA, Bullock AN, Cuny GD, Yu PB . Development of an ALK2-biased BMP type I receptor kinase inhibitor. ACS Chem Biol 2013; 8: 1291\u20131302.","journal-title":"ACS Chem Biol"},{"key":"BFonc2017112_CR23","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.stemcr.2015.10.020","volume":"5","author":"J Cai","year":"2015","unstructured":"Cai J, Orlova VV, Cai X, Eekhoff EM, Zhang K, Pei D et al. Induced pluripotent stem cells to model human fibrodysplasia ossificans progressiva. Stem Cell Rep 2015; 5: 963\u2013970.","journal-title":"Stem Cell Rep"},{"key":"BFonc2017112_CR24","doi-asserted-by":"publisher","first-page":"366ra163","DOI":"10.1126\/scitranslmed.aaf1090","volume":"8","author":"D Dey","year":"2016","unstructured":"Dey D, Bagarova J, Hatsell SJ, Armstrong KA, Huang L, Ermann J et al. Two tissue-resident progenitor lineages drive distinct phenotypes of heterotopic ossification. Sci Transl Med 2016; 8: 366ra163.","journal-title":"Sci Transl Med"},{"key":"BFonc2017112_CR25","doi-asserted-by":"publisher","first-page":"6766","DOI":"10.1523\/JNEUROSCI.0128-13.2013","volume":"33","author":"Y Choe","year":"2013","unstructured":"Choe Y, Kozlova A, Graf D, Pleasure SJ . Bone morphogenic protein signaling is a major determinant of dentate development. J Neurosci 2013; 33: 6766\u20136775.","journal-title":"J Neurosci"},{"key":"BFonc2017112_CR26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.mcn.2013.10.005","volume":"57","author":"M Podkowa","year":"2013","unstructured":"Podkowa M, Christova T, Zhao X, Jian Y, Attisano L . p21-activated kinase (PAK) is required for bone morphogenetic protein (BMP)-induced dendritogenesis in cortical neurons. Mol Cell Neurosci 2013; 57: 83\u201392.","journal-title":"Mol Cell Neurosci"},{"key":"BFonc2017112_CR27","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.neuroscience.2012.06.012","volume":"220","author":"XS Liu","year":"2012","unstructured":"Liu XS, Chopp M, Kassis H, Jia LF, Hozeska-Solgot A, Zhang RL et al. Valproic acid increases white matter repair and neurogenesis after stroke. Neuroscience 2012; 220: 313\u2013321.","journal-title":"Neuroscience"},{"key":"BFonc2017112_CR28","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1038\/ncomms4338","volume":"5","author":"Z Su","year":"2014","unstructured":"Su Z, Niu W, Liu ML, Zou Y, Zhang CL . In vivo conversion of astrocytes to neurons in the injured adult spinal cord. Nat Commun 2014; 5: 3338\u20133352.","journal-title":"Nat Commun"},{"key":"BFonc2017112_CR29","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.stem.2015.07.006","volume":"17","author":"W Hu","year":"2015","unstructured":"Hu W, Qiu B, Guan W, Wang Q, Wang M, Li W et al. Direct conversion of normal and Alzheimer's disease human fibroblasts into neuronal cells by small molecules. Cell Stem Cell 2015; 17: 204\u2013212.","journal-title":"Cell Stem Cell"},{"key":"BFonc2017112_CR30","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1101\/gad.894701","volume":"15","author":"DM Panchision","year":"2001","unstructured":"Panchision DM, Pickel JM, Studer L, Lee SH, Turner PA, Hazel TG et al. Sequential actions of BMP receptors control neural precursor cell production and fate. Genes Dev 2001; 15: 2094\u20132110.","journal-title":"Genes Dev"},{"key":"BFonc2017112_CR31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1756-9966-31-52","volume":"31","author":"S Liu","year":"2012","unstructured":"Liu S, Yin F, Fan W, Wang S, Guo XR, Zhang JN et al. Over-expression of BMPR-IB reduces the malignancy of glioblastoma cells by upregulation of p21 and p27Kip1. J Exp Clin Cancer Res 2012; 31: 52.","journal-title":"J Exp Clin Cancer Res"},{"key":"BFonc2017112_CR32","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1093\/neuonc\/nov310","volume":"18","author":"LD Hover","year":"2016","unstructured":"Hover LD, Owens P, Munden AL, Wang J, Chambless LB, Hopkins CR et al. Bone morphogenetic protein signaling promotes tumorigenesis in a murine model of high-grade glioma. Neuro Oncol 2016; 18: 928\u2013938.","journal-title":"Neuro Oncol"},{"key":"BFonc2017112_CR33","doi-asserted-by":"publisher","first-page":"7711","DOI":"10.1128\/MCB.25.17.7711-7724.2005","volume":"25","author":"SE Kendall","year":"2005","unstructured":"Kendall SE, Battelli C, Irwin S, Mitchell JG, Glackin CA, Verdi JM . NRAGE mediates p38 activation and neural progenitor apoptosis via the bone morphogenetic protein signaling cascade. Mol Cell Biol 2005; 25: 7711\u20137724.","journal-title":"Mol Cell Biol"},{"key":"BFonc2017112_CR34","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/nm904","volume":"9","author":"AR Hallahan","year":"2003","unstructured":"Hallahan AR, Pritchard JI, Chandraratna RA, Ellenbogen RG, Geyer JR, Overland RP et al. BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect. Nat Med 2003; 9: 1033\u20131038.","journal-title":"Nat Med"},{"key":"BFonc2017112_CR35","doi-asserted-by":"crossref","first-page":"16985","DOI":"10.1016\/S0021-9258(17)32506-1","volume":"269","author":"P ten Dijke","year":"1994","unstructured":"ten Dijke P, Yamashita H, Sampath TK, Reddi AH, Estevez M, Riddle DL et al. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J Biol Chem 1994; 269: 16985\u201316988.","journal-title":"J Biol Chem"},{"key":"BFonc2017112_CR36","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1074\/jbc.M706797200","volume":"283","author":"PB Yu","year":"2008","unstructured":"Yu PB, Deng DY, Beppu H, Hong CC, Lai C, Hoyng SA et al. Bone morphogenetic protein (BMP) type II receptor is required for BMP-mediated growth arrest and differentiation in pulmonary artery smooth muscle cells. J Biol Chem 2008; 283: 3877\u20133888.","journal-title":"J Biol Chem"},{"key":"BFonc2017112_CR37","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/ng.2950","volume":"46","author":"AM Fontebasso","year":"2014","unstructured":"Fontebasso AM, Papillon-Cavanagh S, Schwartzentruber J, Nikbakht H, Gerges N, Fiset PO et al. Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma. Nat Genet 2014; 46: 462\u2013466.","journal-title":"Nat Genet"},{"key":"BFonc2017112_CR38","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/ng.2936","volume":"46","author":"P Buczkowicz","year":"2014","unstructured":"Buczkowicz P, Hoeman C, Rakopoulos P, Pajovic S, Letourneau L, Dzamba M et al. Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations. Nat Genet 2014; 46: 451\u2013456.","journal-title":"Nat Genet"},{"key":"BFonc2017112_CR39","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/ng.2925","volume":"46","author":"KR Taylor","year":"2014","unstructured":"Taylor KR, Mackay A, Truffaux N, Butterfield YS, Morozova O, Philippe C et al. Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma. Nat Genet 2014; 46: 457\u2013461.","journal-title":"Nat Genet"},{"key":"BFonc2017112_CR40","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nrclinonc.2012.87","volume":"9","author":"C Jones","year":"2012","unstructured":"Jones C, Perryman L, Hargrave D . Paediatric and adult malignant glioma: close relatives or distant cousins? Nat Rev Clin Oncol 2012; 9: 400\u2013413.","journal-title":"Nat Rev Clin Oncol"},{"key":"BFonc2017112_CR41","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0014-5793(01)02398-5","volume":"496","author":"GT Park","year":"2001","unstructured":"Park GT, Denning MF, Morasso MI . Phosphorylation of murine homeodomain protein Dlx3 by protein kinase C. FEBS Lett 2001; 496: 60\u201365.","journal-title":"FEBS Lett"},{"key":"BFonc2017112_CR42","first-page":"2004","volume":"115","author":"H Li","year":"2014","unstructured":"Li H, Jeong HM, Choi YH, Kim JH, Choi JK, Yeo CY et al. Protein kinase a phosphorylates Dlx3 and regulates the function of Dlx3 during osteoblast differentiation. J Cell Biochem 2014; 115: 2004\u20132011.","journal-title":"J Cell Biochem"},{"key":"BFonc2017112_CR43","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S1044-7431(03)00016-2","volume":"23","author":"GL Andrews","year":"2003","unstructured":"Andrews GL, Yun K, Rubenstein JL, Mastick GS . Dlx transcription factors regulate differentiation of dopaminergic neurons of the ventral thalamus. Mol Cell Neurosci 2003; 23: 107\u2013120.","journal-title":"Mol Cell Neurosci"},{"key":"BFonc2017112_CR44","doi-asserted-by":"publisher","first-page":"7953","DOI":"10.1158\/0008-5472.CAN-09-2006","volume":"69","author":"T Hide","year":"2009","unstructured":"Hide T, Takezaki T, Nakatani Y, Nakamura H, Kuratsu J, Kondo T . Sox11 prevents tumorigenesis of glioma-initiating cells by inducing neuronal differentiation. Cancer Res 2009; 69: 7953\u20137959.","journal-title":"Cancer Res"},{"key":"BFonc2017112_CR45","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/glia.22429","volume":"61","author":"PO Guichet","year":"2013","unstructured":"Guichet PO, Bieche I, Teigell M, Serguera C, Rothhut B, Rigau V et al. Cell death and neuronal differentiation of glioblastoma stem-like cells induced by neurogenic transcription factors. Glia 2013; 61: 225\u2013239.","journal-title":"Glia"},{"key":"BFonc2017112_CR46","doi-asserted-by":"publisher","first-page":"11726","DOI":"10.1158\/0008-5472.CAN-06-1978","volume":"66","author":"M Santra","year":"2006","unstructured":"Santra M, Zhang X, Santra S, Jiang F, Chopp M . Ectopic doublecortin gene expression suppresses the malignant phenotype in glioblastoma cells. Cancer Res 2006; 66: 11726\u201311735.","journal-title":"Cancer Res"},{"key":"BFonc2017112_CR47","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.ccr.2011.01.035","volume":"19","author":"S Mehta","year":"2011","unstructured":"Mehta S, Huillard E, Kesari S, Maire CL, Golebiowski D, Harrington EP et al. The central nervous system-restricted transcription factor Olig2 opposes p53 responses to genotoxic damage in neural progenitors and malignant glioma. Cancer Cell 2011; 19: 359\u2013371.","journal-title":"Cancer Cell"},{"key":"BFonc2017112_CR48","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.ccr.2010.10.023","volume":"18","author":"J Anido","year":"2010","unstructured":"Anido J, S\u00e1ez-Border\u00edas A, Gonz\u00e0lez-Junc\u00e0 A, Rod\u00f3n L, Folch G, Carmona MA et al. TGF-\u03b2 receptor inhibitors target the CD44high\/Id1high glioma-initiating cell population in human glioblastoma. Cancer Cell 2010; 18: 655\u2013668.","journal-title":"Cancer Cell"},{"key":"BFonc2017112_CR49","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3858\/emm.2009.41.2.014","volume":"41","author":"BS Moon","year":"2009","unstructured":"Moon BS, Yoon JY, Kim MY, Lee SH, Choi T, Choi KY . Bone morphogenetic protein 4 stimulates neuronal differentiation of neuronal stem cells through the ERK pathway. Exp Mol Med 2009; 41: 116\u2013125.","journal-title":"Exp Mol Med"},{"key":"BFonc2017112_CR50","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.stem.2009.08.018","volume":"5","author":"H Ikushima","year":"2009","unstructured":"Ikushima H, Todo T, Ino Y, Takahashi M, Miyazawa K, Miyazono K . Autocrine TGF-\u03b2 signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors. Cell Stem Cell 2009; 5: 504\u2013514.","journal-title":"Cell Stem Cell"},{"key":"BFonc2017112_CR51","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1091\/mbc.10.11.3801","volume":"10","author":"M Fujii","year":"1999","unstructured":"Fujii M, Takeda K, Imamura T, Aoki H, Sampath TK, Enomoto S et al. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol Biol Cell 1999; 10: 3801\u20133813.","journal-title":"Mol Biol Cell"},{"key":"BFonc2017112_CR52","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.ajpath.2015.01.011","volume":"185","author":"Y Hoshino","year":"2015","unstructured":"Hoshino Y, Nishida J, Katsuno Y, Koinuma D, Aoki T, Kokudo N et al. Smad4 decreases the population of pancreatic cancer-initiating cells through transcriptional repression of ALDH1A1. Am J Pathol 2015; 185: 1457\u20131470.","journal-title":"Am J Pathol"},{"key":"BFonc2017112_CR53","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1349-7006.2006.00357.x","volume":"98","author":"S Ehata","year":"2007","unstructured":"Ehata S, Hanyu A, Fujime M, Katsuno Y, Fukunaga E, Goto K et al. Ki26894, a novel transforming growth factor-beta type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line. Cancer Sci 2007; 98: 127\u2013133.","journal-title":"Cancer Sci"},{"key":"BFonc2017112_CR54","doi-asserted-by":"publisher","first-page":"5000","DOI":"10.1038\/onc.2016.35","volume":"35","author":"T Sakurai","year":"2016","unstructured":"Sakurai T, Isogaya K, Sakai S, Morikawa M, Morishita Y, Ehata S et al. RNA-binding motif protein 47 inhibits Nrf2 activity to suppress tumor growth in lung adenocarcinoma. Oncogene 2016; 35: 5000\u20135009.","journal-title":"Oncogene"},{"key":"BFonc2017112_CR55","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2012; 2: 401\u2013404.","journal-title":"Cancer Discov"},{"key":"BFonc2017112_CR56","doi-asserted-by":"publisher","first-page":"l1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 2013; 6: l1.","journal-title":"Sci Signal"},{"key":"BFonc2017112_CR57","doi-asserted-by":"publisher","first-page":"3514","DOI":"10.1038\/onc.2015.412","volume":"35","author":"A Mizutani","year":"2016","unstructured":"Mizutani A, Koinuma D, Seimiya H, Miyazono K . The Arkadia-ESRP2 axis suppresses tumor progression: analyses in clear-cell renal cell carcinoma. Oncogene 2016; 35: 3514\u20133523.","journal-title":"Oncogene"},{"key":"BFonc2017112_CR58","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nprot.2012.016","volume":"7","author":"C Trapnell","year":"2012","unstructured":"Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc 2012; 7: 562\u2013578.","journal-title":"Nat Protoc"},{"key":"BFonc2017112_CR59","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/nar\/gku1120","volume":"43","author":"Y Kodama","year":"2015","unstructured":"Kodama Y, Mashima J, Kosuge T, Katayama T, Fujisawa T, Kaminuma E et al. The DDBJ Japanese Genotype-phenotype Archive for genetic and phenotypic human data. Nucleic Acids Res 2015; 43: 18\u201322.","journal-title":"Nucleic Acids Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2017112.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2017112","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/onc.2017.112","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/onc2017112.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T20:20:05Z","timestamp":1647894005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2017112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,1]]},"references-count":59,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2017,8,31]]}},"alternative-id":["BFonc2017112"],"URL":"https:\/\/doi.org\/10.1038\/onc.2017.112","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,1]]},"assertion":[{"value":"16 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}